u 87mg atcc cells Search Results


human glioblastoma u 87mg atcc cells  (ATCC)
99
ATCC human glioblastoma u 87mg atcc cells
Human Glioblastoma U 87mg Atcc Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human glioblastoma u 87mg atcc cells/product/ATCC
Average 99 stars, based on 1 article reviews
human glioblastoma u 87mg atcc cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
human glioblastoma cell line u-87mg  (Korean Cell Line Bank)
90
Korean Cell Line Bank human glioblastoma cell line u-87mg
Human Glioblastoma Cell Line U 87mg, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human glioblastoma cell line u-87mg/product/Korean Cell Line Bank
Average 90 stars, based on 1 article reviews
human glioblastoma cell line u-87mg - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human u-87mg glioblastoma cell line  (Taconic Biosciences)
90
Taconic Biosciences human u-87mg glioblastoma cell line
Human U 87mg Glioblastoma Cell Line, supplied by Taconic Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human u-87mg glioblastoma cell line/product/Taconic Biosciences
Average 90 stars, based on 1 article reviews
human u-87mg glioblastoma cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
u-87mg glioblastoma cells  (Envigo)
90
Envigo u-87mg glioblastoma cells
U 87mg Glioblastoma Cells, supplied by Envigo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u-87mg glioblastoma cells/product/Envigo
Average 90 stars, based on 1 article reviews
u-87mg glioblastoma cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human glioma cell lines  (ATCC)
99
ATCC human glioma cell lines
Human Glioma Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human glioma cell lines/product/ATCC
Average 99 stars, based on 1 article reviews
human glioma cell lines - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
u-87mg–luc cells (1 × 10 5 )  (Harlan Laboratories)
90
Harlan Laboratories u-87mg–luc cells (1 × 10 5 )
Effect of intracranially delivered FF on glioblastoma tumor growth. (A) Effect of FF on the clonogenic growth of <t>U-87MG</t> human glioblastoma cells stably expressing the luciferase reporter <t>(U-87MG–luc),</t> which were used in intracranial glioblastoma model. (B) Measurement of intracranial tumor growth after intracranial injection of FF. U-87MG–luc cells (1 × 105) were implanted into the brains of immunodeficient mice (Foxn1nu; Harlan Laboratories). Tumor-bearing mice were subsequently treated with 5 μl of DMSO (control) or 5 μl of 1 mM FF in DMSO by injection at the same place where the tumor cells were implanted. Two weeks later, bioluminescence imaging was done with the Xenogen IVIS 200 system. Tumor size is expressed as radiance (photons/s/cm2/sr) and was quantified with the Living Image 4.1 software according to the manufacturer's recommendations (Xenogen). Data in panel C represent the average radiance from 10 mice ± the standard deviation calculated from two separate experiments. An asterisk indicates a value statistically significantly different from that of DMSO-treated control mice.
U 87mg–Luc Cells (1 × 10 5 ), supplied by Harlan Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u-87mg–luc cells (1 × 10 5 )/product/Harlan Laboratories
Average 90 stars, based on 1 article reviews
u-87mg–luc cells (1 × 10 5 ) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
b16 f10  (ATCC)
99
ATCC b16 f10
Effect of intracranially delivered FF on glioblastoma tumor growth. (A) Effect of FF on the clonogenic growth of <t>U-87MG</t> human glioblastoma cells stably expressing the luciferase reporter <t>(U-87MG–luc),</t> which were used in intracranial glioblastoma model. (B) Measurement of intracranial tumor growth after intracranial injection of FF. U-87MG–luc cells (1 × 105) were implanted into the brains of immunodeficient mice (Foxn1nu; Harlan Laboratories). Tumor-bearing mice were subsequently treated with 5 μl of DMSO (control) or 5 μl of 1 mM FF in DMSO by injection at the same place where the tumor cells were implanted. Two weeks later, bioluminescence imaging was done with the Xenogen IVIS 200 system. Tumor size is expressed as radiance (photons/s/cm2/sr) and was quantified with the Living Image 4.1 software according to the manufacturer's recommendations (Xenogen). Data in panel C represent the average radiance from 10 mice ± the standard deviation calculated from two separate experiments. An asterisk indicates a value statistically significantly different from that of DMSO-treated control mice.
B16 F10, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b16 f10/product/ATCC
Average 99 stars, based on 1 article reviews
b16 f10 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
u-87mg  (National Centre for Cell Science)
90
National Centre for Cell Science u-87mg
Effect of intracranially delivered FF on glioblastoma tumor growth. (A) Effect of FF on the clonogenic growth of <t>U-87MG</t> human glioblastoma cells stably expressing the luciferase reporter <t>(U-87MG–luc),</t> which were used in intracranial glioblastoma model. (B) Measurement of intracranial tumor growth after intracranial injection of FF. U-87MG–luc cells (1 × 105) were implanted into the brains of immunodeficient mice (Foxn1nu; Harlan Laboratories). Tumor-bearing mice were subsequently treated with 5 μl of DMSO (control) or 5 μl of 1 mM FF in DMSO by injection at the same place where the tumor cells were implanted. Two weeks later, bioluminescence imaging was done with the Xenogen IVIS 200 system. Tumor size is expressed as radiance (photons/s/cm2/sr) and was quantified with the Living Image 4.1 software according to the manufacturer's recommendations (Xenogen). Data in panel C represent the average radiance from 10 mice ± the standard deviation calculated from two separate experiments. An asterisk indicates a value statistically significantly different from that of DMSO-treated control mice.
U 87mg, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u-87mg/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
u-87mg - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
idh1 mutant u87 isogenic cells  (ATCC)
99
ATCC idh1 mutant u87 isogenic cells
Effect of intracranially delivered FF on glioblastoma tumor growth. (A) Effect of FF on the clonogenic growth of <t>U-87MG</t> human glioblastoma cells stably expressing the luciferase reporter <t>(U-87MG–luc),</t> which were used in intracranial glioblastoma model. (B) Measurement of intracranial tumor growth after intracranial injection of FF. U-87MG–luc cells (1 × 105) were implanted into the brains of immunodeficient mice (Foxn1nu; Harlan Laboratories). Tumor-bearing mice were subsequently treated with 5 μl of DMSO (control) or 5 μl of 1 mM FF in DMSO by injection at the same place where the tumor cells were implanted. Two weeks later, bioluminescence imaging was done with the Xenogen IVIS 200 system. Tumor size is expressed as radiance (photons/s/cm2/sr) and was quantified with the Living Image 4.1 software according to the manufacturer's recommendations (Xenogen). Data in panel C represent the average radiance from 10 mice ± the standard deviation calculated from two separate experiments. An asterisk indicates a value statistically significantly different from that of DMSO-treated control mice.
Idh1 Mutant U87 Isogenic Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/idh1 mutant u87 isogenic cells/product/ATCC
Average 99 stars, based on 1 article reviews
idh1 mutant u87 isogenic cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
u 87mg cells  (Dojindo Labs)
99
Dojindo Labs u 87mg cells
Effect of intracranially delivered FF on glioblastoma tumor growth. (A) Effect of FF on the clonogenic growth of <t>U-87MG</t> human glioblastoma cells stably expressing the luciferase reporter <t>(U-87MG–luc),</t> which were used in intracranial glioblastoma model. (B) Measurement of intracranial tumor growth after intracranial injection of FF. U-87MG–luc cells (1 × 105) were implanted into the brains of immunodeficient mice (Foxn1nu; Harlan Laboratories). Tumor-bearing mice were subsequently treated with 5 μl of DMSO (control) or 5 μl of 1 mM FF in DMSO by injection at the same place where the tumor cells were implanted. Two weeks later, bioluminescence imaging was done with the Xenogen IVIS 200 system. Tumor size is expressed as radiance (photons/s/cm2/sr) and was quantified with the Living Image 4.1 software according to the manufacturer's recommendations (Xenogen). Data in panel C represent the average radiance from 10 mice ± the standard deviation calculated from two separate experiments. An asterisk indicates a value statistically significantly different from that of DMSO-treated control mice.
U 87mg Cells, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u 87mg cells/product/Dojindo Labs
Average 99 stars, based on 1 article reviews
u 87mg cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
u-87mg-luc tumor cells  (Caliper Life Sciences)
90
Caliper Life Sciences u-87mg-luc tumor cells
Effect of intracranially delivered FF on glioblastoma tumor growth. (A) Effect of FF on the clonogenic growth of <t>U-87MG</t> human glioblastoma cells stably expressing the luciferase reporter <t>(U-87MG–luc),</t> which were used in intracranial glioblastoma model. (B) Measurement of intracranial tumor growth after intracranial injection of FF. U-87MG–luc cells (1 × 105) were implanted into the brains of immunodeficient mice (Foxn1nu; Harlan Laboratories). Tumor-bearing mice were subsequently treated with 5 μl of DMSO (control) or 5 μl of 1 mM FF in DMSO by injection at the same place where the tumor cells were implanted. Two weeks later, bioluminescence imaging was done with the Xenogen IVIS 200 system. Tumor size is expressed as radiance (photons/s/cm2/sr) and was quantified with the Living Image 4.1 software according to the manufacturer's recommendations (Xenogen). Data in panel C represent the average radiance from 10 mice ± the standard deviation calculated from two separate experiments. An asterisk indicates a value statistically significantly different from that of DMSO-treated control mice.
U 87mg Luc Tumor Cells, supplied by Caliper Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u-87mg-luc tumor cells/product/Caliper Life Sciences
Average 90 stars, based on 1 article reviews
u-87mg-luc tumor cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
u 87mg lysates  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology u 87mg lysates
Effect of intracranially delivered FF on glioblastoma tumor growth. (A) Effect of FF on the clonogenic growth of <t>U-87MG</t> human glioblastoma cells stably expressing the luciferase reporter <t>(U-87MG–luc),</t> which were used in intracranial glioblastoma model. (B) Measurement of intracranial tumor growth after intracranial injection of FF. U-87MG–luc cells (1 × 105) were implanted into the brains of immunodeficient mice (Foxn1nu; Harlan Laboratories). Tumor-bearing mice were subsequently treated with 5 μl of DMSO (control) or 5 μl of 1 mM FF in DMSO by injection at the same place where the tumor cells were implanted. Two weeks later, bioluminescence imaging was done with the Xenogen IVIS 200 system. Tumor size is expressed as radiance (photons/s/cm2/sr) and was quantified with the Living Image 4.1 software according to the manufacturer's recommendations (Xenogen). Data in panel C represent the average radiance from 10 mice ± the standard deviation calculated from two separate experiments. An asterisk indicates a value statistically significantly different from that of DMSO-treated control mice.
U 87mg Lysates, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u 87mg lysates/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
u 87mg lysates - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Effect of intracranially delivered FF on glioblastoma tumor growth. (A) Effect of FF on the clonogenic growth of U-87MG human glioblastoma cells stably expressing the luciferase reporter (U-87MG–luc), which were used in intracranial glioblastoma model. (B) Measurement of intracranial tumor growth after intracranial injection of FF. U-87MG–luc cells (1 × 105) were implanted into the brains of immunodeficient mice (Foxn1nu; Harlan Laboratories). Tumor-bearing mice were subsequently treated with 5 μl of DMSO (control) or 5 μl of 1 mM FF in DMSO by injection at the same place where the tumor cells were implanted. Two weeks later, bioluminescence imaging was done with the Xenogen IVIS 200 system. Tumor size is expressed as radiance (photons/s/cm2/sr) and was quantified with the Living Image 4.1 software according to the manufacturer's recommendations (Xenogen). Data in panel C represent the average radiance from 10 mice ± the standard deviation calculated from two separate experiments. An asterisk indicates a value statistically significantly different from that of DMSO-treated control mice.

Journal: Molecular and Cellular Biology

Article Title: Molecular Mechanisms of Fenofibrate-Induced Metabolic Catastrophe and Glioblastoma Cell Death

doi: 10.1128/MCB.00562-14

Figure Lengend Snippet: Effect of intracranially delivered FF on glioblastoma tumor growth. (A) Effect of FF on the clonogenic growth of U-87MG human glioblastoma cells stably expressing the luciferase reporter (U-87MG–luc), which were used in intracranial glioblastoma model. (B) Measurement of intracranial tumor growth after intracranial injection of FF. U-87MG–luc cells (1 × 105) were implanted into the brains of immunodeficient mice (Foxn1nu; Harlan Laboratories). Tumor-bearing mice were subsequently treated with 5 μl of DMSO (control) or 5 μl of 1 mM FF in DMSO by injection at the same place where the tumor cells were implanted. Two weeks later, bioluminescence imaging was done with the Xenogen IVIS 200 system. Tumor size is expressed as radiance (photons/s/cm2/sr) and was quantified with the Living Image 4.1 software according to the manufacturer's recommendations (Xenogen). Data in panel C represent the average radiance from 10 mice ± the standard deviation calculated from two separate experiments. An asterisk indicates a value statistically significantly different from that of DMSO-treated control mice.

Article Snippet: U-87MG–luc cells (1 × 10 5 ) were implanted into the brains of immunodeficient mice (Foxn1 nu ; Harlan Laboratories).

Techniques: Stable Transfection, Expressing, Luciferase, Injection, Imaging, Software, Standard Deviation

Metabolic and survival responses of glial cells to FF. (A to D) Effects of FF on OCR in monolayer cultures of NHA, primary human GBM cells, and two human glioblastoma cell lines, LN-229 and U-87MG. OCR values were registered in serum-free XF assay medium following the sequential injection of FF (50 μM), oligomycin (0.3 μM), FCCP (0.5 μM), and rotenone (0.3 μM). Control cells were injected with DMSO in XF medium. The results are average OCR values from three experiments performed in triplicate (n = 9) ± the standard deviations. An asterisk indicates a statistically significant difference between control and FF-treated samples (percent decrease in OCR after FF injection), two asterisks indicate a statistically significant difference between percent decreases in OCR after oligomycin injection, three asterisks indicate a statistically significant difference between percent increases in OCR after FCCP injection, and four asterisks indicate a statistically significant difference between percent decreases in OCR after rotenone injection. (E) Survival of LN-229, U-87MG, and primary GBM cells and NHA evaluated with the flow cytometry-based 7-AAD assay. Cells were cultured in the corresponding growth-promoting media in the presence or absence of 25 or 50 μM FF for 72 h. The data are average values from three experiments performed in triplicate (n = 9). An asterisk indicates a statistically significant difference from the corresponding control, two asterisks indicate a statistically significant difference between NHA and LN-229, three asterisks indicate a statistically significant difference between NHA and U-87MG, and four asterisks indicate a statistically significant difference between NHA and GBM. (F) GFAP/DAPI-labeled primary gliosphere that was allowed to adhere and spread following 5 weeks of continuous growth in suspension. Note that all tumor cells are positive for the glial marker GFAP.

Journal: Molecular and Cellular Biology

Article Title: Molecular Mechanisms of Fenofibrate-Induced Metabolic Catastrophe and Glioblastoma Cell Death

doi: 10.1128/MCB.00562-14

Figure Lengend Snippet: Metabolic and survival responses of glial cells to FF. (A to D) Effects of FF on OCR in monolayer cultures of NHA, primary human GBM cells, and two human glioblastoma cell lines, LN-229 and U-87MG. OCR values were registered in serum-free XF assay medium following the sequential injection of FF (50 μM), oligomycin (0.3 μM), FCCP (0.5 μM), and rotenone (0.3 μM). Control cells were injected with DMSO in XF medium. The results are average OCR values from three experiments performed in triplicate (n = 9) ± the standard deviations. An asterisk indicates a statistically significant difference between control and FF-treated samples (percent decrease in OCR after FF injection), two asterisks indicate a statistically significant difference between percent decreases in OCR after oligomycin injection, three asterisks indicate a statistically significant difference between percent increases in OCR after FCCP injection, and four asterisks indicate a statistically significant difference between percent decreases in OCR after rotenone injection. (E) Survival of LN-229, U-87MG, and primary GBM cells and NHA evaluated with the flow cytometry-based 7-AAD assay. Cells were cultured in the corresponding growth-promoting media in the presence or absence of 25 or 50 μM FF for 72 h. The data are average values from three experiments performed in triplicate (n = 9). An asterisk indicates a statistically significant difference from the corresponding control, two asterisks indicate a statistically significant difference between NHA and LN-229, three asterisks indicate a statistically significant difference between NHA and U-87MG, and four asterisks indicate a statistically significant difference between NHA and GBM. (F) GFAP/DAPI-labeled primary gliosphere that was allowed to adhere and spread following 5 weeks of continuous growth in suspension. Note that all tumor cells are positive for the glial marker GFAP.

Article Snippet: U-87MG–luc cells (1 × 10 5 ) were implanted into the brains of immunodeficient mice (Foxn1 nu ; Harlan Laboratories).

Techniques: XF Assay, Injection, Flow Cytometry, Cell Culture, Labeling, Marker